RxDoctor Payments Data

Tonda Anderson, MD

Family Medicine · Mount Washington, KYNPI 1649278359

Payments from drug & device makers

$746in general payments, 2019–2025

Across 47 payments — averaging $15.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$127
  • GSK$118
  • Merck$85
  • AstraZeneca$84
  • Pfizer$65
  • Amgen$59
  • plus $208 from 9 others

What the payments were for

  • Food & beverage$746100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$746 in reported general payments places this provider in the 50th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$20,286
Medicare patients
87
Services billed
374

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide12$30,881
EliquisApixaban25$27,686
JardianceEmpagliflozin23$25,762
OzempicSemaglutide27$25,052
FarxigaDapagliflozin Propanediol15$20,404
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$17,264
Tresiba Flextouch U-200Insulin Degludec18$16,196
Janumet XrSitagliptin Phos/Metformin Hcl13$14,620
Breo ElliptaFluticasone/Vilanterol13$9,041
Combivent RespimatIpratropium/Albuterol Sulfate13$6,124
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$5,449
JentaduetoLinagliptin/Metformin Hcl11$4,474
Venlafaxine Hcl ErVenlafaxine Hcl15$3,068
Albuterol Sulfate HfaAlbuterol Sulfate48$1,595
Ultra-Fine Mini Pen NeedlePen Needle, Diabetic22$1,269

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Combivent Respimat, Jentadueto$49$36,36147 claims
Lilly USA, LLCTrulicity$127$30,88112 claims
PfizerEliquis$65$27,68625 claims
GSKTrelegy Ellipta, Breo Ellipta$118$26,30528 claims
Novo NordiskOzempic$13$25,05227 claims
AstraZenecaFarxiga$84$20,40415 claims
MerckJanumet Xr$85$14,62013 claims
AbbVieSynthroid$35$1,20516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Mount Washington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →